ÀڱðæºÎ¾ÏÀÇ ¼±º°°Ë»ç¿¡ ÀÖ¾î Çѱ¹Çü ÀڱðæºÎ È®´ëÃÔ¿µ¼úÀÇ ÀÓ»óÀû À¯¿ë¼º
Clinical Usefulness of New Cervicography in Screening of Cervical Cancer

´ëÇÑ»êºÎÀΰúÇÐȸÁö 2000³â 43±Ç 5È£ p.777 ~ p.786

ÀÌ¿ë¼®(Lee Yong-Seok) - Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
±èµ¿È£(Kim Dong-Ho) - Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç

Abstract

¸ñÀû : ÀڱðæºÎ ¼¼Æ÷Áø°Ë»ç ¹× Çѱ¹Çü ÀڱðæºÎ È®´ëÃÔ¿µ¼úÀ» µ¿½Ã¿¡ ½ÃÇàÇß´ø ȯÀÚ¸¦ ´ë»óÀ¸·Î ÀڱðæºÎ¾ÏÀÇ ¼±º°°Ë»ç¿¡ À־ Çѱ¹Çü ÀڱðæºÎ È®´ëÃÔ¿µ¼úÀÇ À¯¿ë¼ºÀ» ¾Ë¾Æº¸°í ¼¼Æ÷Áø°Ë»ç¿Í ºñ±³Çغ¸°íÀÚ ÇÏ¿´´Ù.

¿¬±¸¹æ¹ý: 1998³â 9¿ùºÎÅÍ 1999³â 8¿ù±îÁö Áß¾Ó´ëÇб³ ºÎ¼Ó Çʵ¿º´¿ø »êºÎÀΰú ¿Ü·¡¿¡ ¹æ¹®ÇÏ¿© ¼¼Æ÷Áø°Ë»ç¿Í ÀڱðæºÎ È®´ëÃÔ¿µ¼úÀ» µ¿½Ã¿¡ ½ÃÇàÇÑ 189·Ê¸¦ ´ë»óÀ¸·Î ÇÏ¿´´Âµ¥, ¼¼Æ÷Áø°Ë»ç ¶Ç´Â ÀڱðæºÎ È®´ëÃÔ¿µ¼ú¿¡¼­ ¾ç¼º º´º¯ÀÇ ¼Ò°ßÀ» º¸ÀÎ 84·Ê ¸ðµÎ¿¡¼­ ÁúÈ®´ë°æ Á¶ÁØÇÏ »ý°ËÀ» ½ÃÇàÇÏ¿´°í, ¼¼Æ÷Áø°Ë»ç¿¡¼­ ASCUS(atypical squamous cells of undetermined significance)³ª ÀڱðæºÎ È®´ëÃÔ¿µ¼ú¿¡¼­ Benign atypical ȤÀº Suspicious atypical(S1)·Î ³ª¿Í ºÎ¼öÀûÀ¸·Î Á¶Á÷°Ë»ç°¡ ±Ç°íµÈ 3·Ê¸¦ Æ÷ÇÔÇؼ­ °á±¹ ÀڱðæºÎ »ý°ËÀº 87·Ê¿¡¼­ ½ÃÇàµÇ¾ú´Ù.

¿¬±¸°á°ú : ÀڱðæºÎ È®´ëÃÔ¿µ¼úÀº ¼¼Æ÷Áø°Ë»ç¿¡ ºñÇØ ¹Î°¨µµ°¡ À¯ÀÇÇÏ°Ô ³ô¾ÒÀ¸¸ç(92.2% vs 60.8%, p<0.01) À§À½¼º·üÀº À¯ÀÇÇÏ°Ô ³·¾Ò´Ù(7.8% vs 39.2%, p<0.01). ¼¼Æ÷Áø°Ë»ç´Â ÀڱðæºÎ È®´ëÃÔ¿µ¼ú¿¡ ºñÇØ Æ¯À̵µ(99.3% vs 75.0%, p<0.05), ¼º¿¹Ãø·ü(96.8% vs 58.0%, p<0.01)ÀÌ À¯ÀÇÇÏ°Ô ³ô¾ÒÀ¸¸ç À§¾ç¼º·ü(0.7% vs 25.0%, p<0.01)Àº À¯ÀÇÇÏ°Ô ³·¾Ò´Ù. µÎ °Ë»ç¸¦ º´¿ëÇÏ¿´À»¶§´Â ¼¼Æ÷Áø°Ë»ç ´Üµ¶º¸´Ù ¹Î°¨µµ(p<0.01)°¡ À¯ÀÇÇÏ°Ô ³ô¾ÆÁ³À¸¸ç, À§À½¼º·üÀº À¯ÀÇÇÏ°Ô ³·¾ÆÁ³´Ù(p<0.01). ±×·¯³ª ¼¼Æ÷Áø°Ë»ç ´Üµ¶º¸´Ù À§¾ç¼º·üÀº À¯ÀÇÇÏ°Ô ³ô¾ÆÁ³À¸¸ç, ƯÀ̵µ¿Í ¾ç¼º¿¹Ãø·üÀº À¯ÀÇÇÏ°Ô ³·¾ÆÁ³´Ù.

°á·Ð : ÀڱðæºÎ È®´ëÃÔ¿µ¼úÀÌ ¼¼Æ÷Áø°Ë»ç³ª ÁúÈ®´ë°æ°Ë»ç¸¦ ¿ÏÀüÈ÷ ´ë½ÅÇÒ ¼ö´Â ¾øÁö¸¸ ÀÌ µÎ°Ë»ç´Â ¼­·Î »óÈ£ º¸¿ÏÀûÀ̱⠶§¹®¿¡ ¼¼Æ÷Áø°Ë»ç¿Í ÇÔ²² »ç¿ëÇÏ¿©¾ß ÇÏ¸ç µÎ°Ë»çÁß ¾î´À Çϳª¶óµµ ºñÁ¤»óÀ¸·Î ³ª¿Â °æ¿ì ÁúÈ®´ë°æ°Ë»ç·Î Á¶Á÷°Ë»ç¸¦ ¹Þµµ·Ï ÇÑ´Ù¸é ÀڱðæºÎ¾ÏÀÇ ¿¹¹æ ¹× Á¶±âÄ¡·áÀÇ °¡´É¼ºÀ» ³ô¿© ÀڱðæºÎ¾ÏÀ¸·Î ÀÎÇÑ »ç¸Á·üÀ» °¨¼Ò½ÃÅ°´Âµ¥ Å« ±â¿©¸¦ ÇÒ °ÍÀ¸·Î »ç·áµÈ´Ù.
Objective: This study was performed to evaluate the usefulness of New cervicography by comparing cervicographic finding with Papanicolaou smear and result of colposcopically directed biopsy.

Methods: This study group consisted of 189 patients who visited the Department of Obstetrics and Gynecology, Chung-Ang University Pildong Hospital from September 1998 to August 1999. All women simultaneously underwent Papanicolaou smear and New cervicography. If either method was positive, the patient was referred for colposcopically directed biopsy.

Results: The New cervicography was significantly more sensitive than the Papanicolaou smear(92.2% vs 60.8%, p<0.01), whereas the Papanicolaou smear was significantly more specific than the New cervicography(99.3% vs 75.0%, p<0.05). The false positive rate of New cervicography was 75%, significantly higher than 0.7% of Papanicolaou smear. There was no significant difference between the negative predictive value of cervicography and Papanicolaou smear. When New cervicography and Papanicolaou smear were used together, the sensitivity was significantly higher than Papanicolaou smear used alone(98.1% vs 60.8%, p<0.01) and false negative rate was significantly lower than Papanicolaou
smear(1.9% vs 39.2%, p<0.01). However the specificity, positive predictive value of the combined test were lower than Papanicolaou smear.

Conclusion: Cervicography is one of the Papanicolaou smear adjunctive tests and a useful method to detect cervical cancer. Our study confirms the previously suspected low sensitivity of Papanicolaou smear and demonstrate that cervicography is more sensitive than Papanicolaou smear and less specific. From the above results, when New cervicography and Papanicolaou smear were used together, the detection rate of cervical cancer will be increased more easily since the cases missed by one method may be picked up by another.

Å°¿öµå

Çѱ¹Çü ÀڱðæºÎ È®´ëÃÔ¿µ¼ú, ¼¼Æ÷Áø°Ë»ç, ¼±º°°Ë»ç, ÀڱðæºÎ¾Ï
New Cervicography, Papanicolaou smear, Screening, Cervical cancer
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Cervicography is more sensitive than Papanicolaou smear and less specific. From the above results, when New cervicography and Papanicolaou smear were used together, the detection rate of cervical cancer will be increased more easily.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå